AHA Statement on FDA Emergency Use Authorization of Pfizer COVID-19 Vaccine

Rick Pollack
President and CEO
American Hospital Association

December 11, 2020 

America’s hospitals and health systems believe the announcement by the Food and Drug Administration (FDA) of an Emergency Use Authorization (EUA) of the Pfizer COVID-19 vaccine is an important step forward in ending this pandemic. This authorization was made on advice after a careful review by scientific and clinical experts through a thoughtful process. We will continue to be guided by science and follow the evidence that the FDA lays out on the safety and efficacy of the various vaccines in development.

In addition to playing an important role in vaccination efforts across the country, we also know that along with our physician and nursing partners, we have an important role to play in providing the public with clear and concise information that informs them about the benefits of being vaccinated. This is especially important so that the public has the necessary confidence to allow them to make this important decision for their families and loved ones. Because of the long road ahead of us until COVID-19 vaccines are widely available, the AHA continues to urge the American public to wear masks, maintain physical distancing and wash their hands.

###

 Contact:        Colin Milligan, (202) 638-5491, cmilligan@aha.org
                      Marie Johnson, (202) 626-2351, mjohnson@aha.org